Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06400095 · ClinicalTrials.gov registry record
Ventilatory Parameters in Predicting Outcomes in ARDS Patients
A clinical trial of ARDS and Mechanical Power, sponsored by CentraCare.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06400095 is a study of ARDS and Mechanical Power that is actively recruiting participants, run by CentraCare. The registered enrollment target is 50 participants, below the 583-participant average among 14 other ARDS trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06400095, a study of ARDS and Mechanical Power, is actively recruiting participants, sponsored by CentraCare.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-centre prospective observational study aimed to determine if Pocc (occlusion pressure at 100 msec), TCe ( Expiratory time constant ), Mechanical Stress power, Ventilatory ratio and C20/Cdyn would predict outcomes in patients with moderately severe ARDS (Acute respiratory distress syndrome), who are on mechanical ventilation
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Poccl, Time constant, driving pressure
Study Locations (1)
Minnesota
- St Cloud Hospital - Saint Cloud
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2025-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06400095
The ClinicalTrials.gov registry entry for NCT06400095 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 583-participant average among 14 other ARDS trials with a reported enrollment target (91% lower). The listed sponsor is CentraCare, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with ARDS appearing as the primary indexed condition, and to 1 intervention - of which Poccl, Time constant, driving pressure is the first listed.
NCT06400095 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06400095 about?
NCT06400095 is a clinical study titled "Ventilatory Parameters in Predicting Outcomes in ARDS Patients". This is a single-centre prospective observational study aimed to determine if Pocc (occlusion pressure at 100 msec), TCe ( Expiratory time constant ), Mechanical Stress power, Ventilatory ratio and C20/Cdyn would predict outcomes in patients with moderately severe ARDS (Acute respiratory distress sy...
What is the current status of trial NCT06400095?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2023-06-01. Estimated completion is 2025-07.
What conditions does trial NCT06400095 study?
This clinical trial studies the following conditions: ARDS, Mechanical Power.
What interventions are being tested in trial NCT06400095?
The interventions under investigation include: Poccl, Time constant, driving pressure (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06400095?
This trial is sponsored by CentraCare, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06400095 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ARDS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
RECRUITING · Phase 2
-
The APS Phenotyping Study
RECRUITING
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
RECRUITING · Phase 2
-
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
RECRUITING · Phase 3
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
RECRUITING · Phase 2
-
Respiratory Knowledge Portal Computer and Phone Application to Improve Quality of Mechanical Ventilation by Reducing the Number of Ventilator Associated Events, Injury Created by the Ventilator and Unsafe Setting of Alarms.
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.